241 related articles for article (PubMed ID: 32654116)
1. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.
Cacciapaglia F; Fornaro M; Venerito V; Perniola S; Urso L; Iannone F
Eur J Clin Invest; 2020 Dec; 50(12):e13343. PubMed ID: 32654116
[TBL] [Abstract][Full Text] [Related]
2. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
3. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
Solomon DH; Reed GW; Kremer JM; Curtis JR; Farkouh ME; Harrold LR; Hochberg MC; Tsao P; Greenberg JD
Arthritis Rheumatol; 2015 Jun; 67(6):1449-55. PubMed ID: 25776112
[TBL] [Abstract][Full Text] [Related]
4. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
[TBL] [Abstract][Full Text] [Related]
5. Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis.
Cafaro G; Perricone C; Riccucci I; Bursi R; Calvacchi S; Alunno A; Carubbi F; Gerli R; Bartoloni E
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):107-113. PubMed ID: 34665709
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.
Erre GL; Cacciapaglia F; Sakellariou G; Manfredi A; Bartoloni E; Viapiana O; Fornaro M; Cauli A; Mangoni AA; Woodman RJ; Palermo BL; Gremese E; Cafaro G; Nucera V; Vacchi C; Spinelli FR; Atzeni F; Piga M;
Eur J Intern Med; 2022 Oct; 104():49-54. PubMed ID: 35821191
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
[TBL] [Abstract][Full Text] [Related]
8. Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions.
Karpouzas GA; Ormseth SR; Hernandez E; Budoff MJ
Arthritis Rheumatol; 2020 Sep; 72(9):1467-1475. PubMed ID: 32319221
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
[TBL] [Abstract][Full Text] [Related]
10. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group.
Cacciapaglia F; Spinelli FR; Piga M; Erre GL; Sakellariou G; Manfredi A; Viapiana O; Fornaro M; Colella S; Floris A; Mangoni AA; Castagna F; Vacchi C; Orsolini G; Bugatti S; Cafaro G; Cauli A; Gremese E; Atzeni F; Bartoloni E
Eur J Intern Med; 2022 Feb; 96():60-65. PubMed ID: 34657778
[TBL] [Abstract][Full Text] [Related]
11. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.
Kang EH; Jin Y; Brill G; Lewey J; Patorno E; Desai RJ; Kim SC
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367417
[TBL] [Abstract][Full Text] [Related]
12. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH; Stanwix AE; Joffe BI
Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
[TBL] [Abstract][Full Text] [Related]
14. Rates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system.
Rashid N; Lin AT; Aranda G; Lin KJ; Guerrero VN; Nadkarni A; Patel C
J Med Econ; 2016 Jun; 19(6):568-75. PubMed ID: 26766553
[TBL] [Abstract][Full Text] [Related]
15. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Ocon AJ; Reed G; Pappas DA; Curtis JR; Kremer JM
Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644
[TBL] [Abstract][Full Text] [Related]
16. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
Liao KP; Liu J; Lu B; Solomon DH; Kim SC
Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator.
Wahlin B; Innala L; Magnusson S; Möller B; Smedby T; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2019 Feb; 46(2):130-137. PubMed ID: 30275258
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Drakopoulou M; Soulaidopoulos S; Oikonomou G; Tousoulis D; Toutouzas K
Curr Vasc Pharmacol; 2020; 18(5):488-506. PubMed ID: 32056527
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.
Nadareishvili Z; Michaud K; Hallenbeck JM; Wolfe F
Arthritis Rheum; 2008 Aug; 59(8):1090-6. PubMed ID: 18668583
[TBL] [Abstract][Full Text] [Related]
20. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
